Intelligent Investor

PharmAust Limited (ASX: PAA) - Announcements

- Current share price for PAA : $0.185

ASX company news and announcements for PharmAust Limited (PAA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PharmAust Limited (PAA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PharmAust Limited (PAA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PharmAust Limited (PAA)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$73 Half Yearly Report & Half Year Accounts 14 Mar 2006 12:33PM $0.180 $0.185 $0.180 risen by 2.78%
$73 Receives TGA Licence 13 Mar 2006 8:29AM $0.190 $0.185 $0.180 fallen by 2.63%
$73 Capital Raising Comple//ted to Raise $2.1 Million 7 Mar 2006 7:15PM $0.185 $0.185 $0.180 fallen by 0%
$73 PAA Sign Three-Year Multi-Million Dollar Global Peptide Deal 14 Feb 2006 2:46PM $0.185 $0.185 $0.180 fallen by 0%
$73 TGA Audit 8 Feb 2006 1:08PM $0.170 $0.185 $0.180 risen by 8.82%
$73 Commitments Test Entity - Second Quarter Report 31 Jan 2006 7:23PM $0.165 $0.185 $0.180 risen by 12.12%
$73 Mimotopes & Genzyme Corporation join forces 27 Jan 2006 8:31AM $0.180 $0.185 $0.180 risen by 2.78%
$73 PharmAust awarded research funding 19 Dec 2005 2:03PM $0.170 $0.185 $0.180 risen by 8.82%
$73 Mimotopes to enter into global peptide business agmt 9 Nov 2005 8:29AM $0.194 $0.185 $0.180 fallen by 4.54%
$73 Disclosure Document 8 Nov 2005 6:17PM $0.194 $0.185 $0.180 fallen by 4.54%
$73 Commitments Test Entity - First Quarter Report 28 Oct 2005 6:39PM n/a $0.185 $0.180 n/a
$73 Secures Major Outsourcing Agreement with Invitrogen 5 Oct 2005 10:04AM $0.209 $0.185 $0.180 fallen by 11.36%
$73 PAA & EQX partnership to develop new therapeutic targets 19 Sep 2005 12:37PM $0.199 $0.185 $0.180 fallen by 6.94%
$73 Preliminary Final Report 13 Sep 2005 12:55PM $0.199 $0.185 $0.180 fallen by 6.94%
$73 Signs breakthrough distribution agreement 2 Sep 2005 12:42PM $0.189 $0.185 $0.180 fallen by 2.01%
$73 Commitments Test Entity - Fourth Quarter Report 25 Jul 2005 1:33PM $0.204 $0.185 $0.180 fallen by 9.18%
$73 Cancellation of Travel Distribution Agreement & Shares 19 Jul 2005 3:33PM $0.199 $0.185 $0.180 fallen by 6.94%
$73 Investment in Intellectual Property Development 15 Jul 2005 10:42AM $0.189 $0.185 $0.180 fallen by 2.01%
$73 Epichem in Drug Royalty Deal with Murdoch University 26 May 2005 2:17PM $0.189 $0.185 $0.180 fallen by 2.01%
$73 Mimotopes Update 19 May 2005 1:16PM $0.179 $0.185 $0.180 risen by 3.41%
$73 Acquisition of Mimotopes Pty Ltd 24 Feb 2005 12:43PM $0.268 $0.185 $0.180 fallen by 31.05%
$73 Short Form Disclosure Document 21 Jan 2005 4:17PM $0.246 $0.185 $0.180 fallen by 24.86%
$73 Option Issue for Shareholders 21 Jan 2005 8:29AM $0.246 $0.185 $0.180 fallen by 24.86%
$73 Trading Halt 2 Dec 2004 10:23AM $0.255 $0.185 $0.180 fallen by 27.45%
$73 Investor Update 1 Dec 2004 9:45AM $0.268 $0.185 $0.180 fallen by 31.02%

726 - 750 of 752 results

Page 30 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.